- Home
- FRST vs ALLO Comparison
FRST vs ALLO Comparison
Compare FRST & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRST | ALLO |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.3M | 483.7M |
| IPO Year | 2006 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FRST | ALLO |
|---|---|---|
| Price | $15.48 | $1.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $18.94 | $9.00 |
| AVG Volume (30 Days) | 110.1K | ★ 5.6M |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ 477.27 | 34.09 |
| EPS | ★ 0.68 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.97 | N/A |
| Revenue Next Year | $8.75 | $255.46 |
| P/E Ratio | $22.71 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.68 | $1.04 |
| 52 Week High | $16.88 | $4.46 |
Technical Indicators
Market Signals| Indicator | FRST | ALLO |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 26.53 |
| Support Level | $15.46 | N/A |
| Resistance Level | $15.80 | $2.22 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 71.84 | 18.82 |
Price Performance
Historical ComparisonAbout FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).